Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial.

Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, Hahne J, Friedrich M.

Pain. 2014 Feb;155(2):261-8. doi: 10.1016/j.pain.2013.10.002.

PMID:
24438771
2.

Calcium nutrition and extracellular calcium sensing: relevance for the pathogenesis of osteoporosis, cancer and cardiovascular diseases.

Peterlik M, Kállay E, Cross HS.

Nutrients. 2013 Jan 22;5(1):302-27. doi: 10.3390/nu5010302. Review.

4.

Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer.

Cross HS, Nittke T, Kallay E.

Mol Cell Endocrinol. 2011 Dec 5;347(1-2):70-9. doi: 10.1016/j.mce.2011.07.022. Epub 2011 Jul 27. Review.

PMID:
21801808
5.

Open letter to IARC Director Christopher P. Wild-Re: IARC Working Group Report 5: Vitamin D and Cancer.

Garland CF, Grant WB, Boucher BJ, Cross HS, Garland FC, Gillie O, Gorham ED, Heaney RP, Holick MF, Hollis BW, Moan JE, Peterlik M, Reichrath J, Zittermann A.

Dermatoendocrinol. 2009 Mar;1(2):119-20. No abstract available.

6.

Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem.

Peterlik M, Boonen S, Cross HS, Lamberg-Allardt C.

Int J Environ Res Public Health. 2009 Oct;6(10):2585-607. doi: 10.3390/ijerph6102585. Epub 2009 Oct 2. Review.

7.

Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology.

Peterlik M, Cross HS.

Eur J Clin Nutr. 2009 Dec;63(12):1377-86. doi: 10.1038/ejcn.2009.105. Epub 2009 Sep 2. Review.

PMID:
19724293
8.
9.

Mutual associations between malignancy, age, gender, and subsite incidence of colorectal cancer.

Brozek W, Kriwanek S, Bonner E, Peterlik M, Cross HS.

Anticancer Res. 2009 Sep;29(9):3721-6.

10.

Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention.

Cross HS, Nittke T, Peterlik M.

Anticancer Res. 2009 Sep;29(9):3705-12. Review.

11.

Calcium, vitamin D and cancer.

Peterlik M, Grant WB, Cross HS.

Anticancer Res. 2009 Sep;29(9):3687-98. Review.

12.

Vitamin D, calcium, and cancer.

Cross HS, Peterlik M.

Anticancer Res. 2009 Sep;29(9):3685. No abstract available.

13.

Regulation of the colonic vitamin D system for prevention of tumor progression: an update.

Cross HS, Kallay E.

Future Oncol. 2009 May;5(4):493-507. doi: 10.2217/fon.09.22. Review.

PMID:
19450178
14.

Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe.

Grant WB, Cross HS, Garland CF, Gorham ED, Moan J, Peterlik M, Porojnicu AC, Reichrath J, Zittermann A.

Prog Biophys Mol Biol. 2009 Feb-Apr;99(2-3):104-13. doi: 10.1016/j.pbiomolbio.2009.02.003. Epub 2009 Mar 4. Review.

PMID:
19268496
15.

Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer.

Mostafaie N, Kállay E, Sauerzapf E, Bonner E, Kriwanek S, Cross HS, Huber KR, Krugluger W.

Mol Carcinog. 2009 Jul;48(7):642-7. doi: 10.1002/mc.20510.

PMID:
19148895
16.

Chemoprevention of colorectal neoplasia by estrogen: potential role of vitamin D activity.

Protiva P, Cross HS, Hopkins ME, Kállay E, Bises G, Dreyhaupt E, Augenlicht L, Lipkin M, Lesser M, Livote E, Holt PR.

Cancer Prev Res (Phila). 2009 Jan;2(1):43-51. doi: 10.1158/1940-6207.CAPR-08-0103.

17.

Nutritional calcium modulates colonic expression of vitamin D receptor and pregnane X receptor target genes.

Nittke T, Selig S, Kallay E, Cross HS.

Mol Nutr Food Res. 2008 Jun;52 Suppl 1:S45-51. doi: 10.1002/mnfr.200700200.

PMID:
18327873
18.

Clone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells.

Brozek W, Bises G, Fabjani G, Cross HS, Peterlik M.

BMC Cancer. 2008 Jan 18;8:13. doi: 10.1186/1471-2407-8-13.

20.

Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors.

Krugluger W, Brandstaetter A, Kállay E, Schueller J, Krexner E, Kriwanek S, Bonner E, Cross HS.

Cancer Res. 2007 Aug 15;67(16):7917-22.

21.

Phytoestrogens in clinical practice: a review of the literature.

Tempfer CB, Bentz EK, Leodolter S, Tscherne G, Reuss F, Cross HS, Huber JC.

Fertil Steril. 2007 Jun;87(6):1243-9. Epub 2007 May 9. Review.

PMID:
17490659
22.

A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.

Lechner D, Manhardt T, Bajna E, Posner GH, Cross HS.

J Pharmacol Exp Ther. 2007 Mar;320(3):1119-26. Epub 2006 Dec 20.

PMID:
17182978
23.

Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon.

Bises G, Bajna E, Manhardt T, Gerdenitsch W, Kallay E, Cross HS.

J Nutr. 2007 Jan;137(1 Suppl):211S-215S. doi: 10.1093/jn/137.1.211S.

PMID:
17182828
24.

1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells.

Lechner D, Kállay E, Cross HS.

Mol Cell Endocrinol. 2007 Jan 15;263(1-2):55-64. Epub 2006 Oct 9.

PMID:
17029768
25.

Genistein and 17beta-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells.

Lechner D, Bajna E, Adlercreutz H, Cross HS.

Anticancer Res. 2006 Jul-Aug;26(4A):2597-603.

26.
27.
28.

Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy.

Cross HS, Lipkin M, Kállay E.

J Nutr. 2006 Mar;136(3):561-4. Review.

PMID:
16484524
29.

Commentary: from epidemiology to molecular biology--vitamin D and colorectal cancer prevention.

Cross HS.

Int J Epidemiol. 2006 Apr;35(2):225-7. Epub 2005 Nov 22. Review. No abstract available.

PMID:
16303805
30.

Differentiation-dependent expression and mitogenic action of interleukin-6 in human colon carcinoma cells: relevance for tumour progression.

Brozek W, Bises G, Girsch T, Cross HS, Kaiser HE, Peterlik M.

Eur J Cancer. 2005 Oct;41(15):2347-54.

PMID:
16176872
31.

The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention.

Cross HS, Bises G, Lechner D, Manhardt T, Kállay E.

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):121-8. Epub 2005 Aug 2.

PMID:
16081282
32.

Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.

Kállay E, Bises G, Bajna E, Bieglmayer C, Gerdenitsch W, Steffan I, Kato S, Armbrecht HJ, Cross HS.

Carcinogenesis. 2005 Sep;26(9):1581-9. Epub 2005 May 19.

PMID:
15905206
33.

Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells.

Khorchide M, Lechner D, Cross HS.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):167-72. Epub 2005 Feb 5.

PMID:
15860259
34.

Vitamin D and calcium deficits predispose for multiple chronic diseases.

Peterlik M, Cross HS.

Eur J Clin Invest. 2005 May;35(5):290-304. Review.

PMID:
15860041
35.

Dietary calcium and colon cancer prevention.

Kállay E, Wrba F, Cross HS.

Forum Nutr. 2003;56:188-90. No abstract available.

PMID:
15806857
36.

Phytoestrogens and colorectal cancer prevention.

Lechner D, Kállay E, Cross HS.

Vitam Horm. 2005;70:169-98. Review.

PMID:
15727805
37.

Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells.

Meindl S, Rot A, Hoetzenecker W, Kato S, Cross HS, Elbe-Bürger A.

Br J Dermatol. 2005 Feb;152(2):231-41.

PMID:
15727633
38.

25-hydroxyvitamin D3-1alpha-hydroxylase expression in normal and malignant human colon.

Bises G, Kállay E, Weiland T, Wrba F, Wenzl E, Bonner E, Kriwanek S, Obrist P, Cross HS.

J Histochem Cytochem. 2004 Jul;52(7):985-9.

PMID:
15208365
39.

Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas.

Cross HS, Kállay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ.

J Nutr. 2004 May;134(5):1207S-1212S. Review.

PMID:
15113973
40.

Regulation of extrarenal synthesis of 1,25-dihydroxyvitamin D3--relevance for colonic cancer prevention and therapy.

Cross HS, Kállay E, Khorchide M, Lechner D.

Mol Aspects Med. 2003 Dec;24(6):459-65. Review.

PMID:
14585316
41.

Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention.

Cross HS, Kállay E, Farhan H, Weiland T, Manhardt T.

Recent Results Cancer Res. 2003;164:413-25.

PMID:
12899539
42.
43.

Molecular and functional characterization of the extracellular calcium-sensing receptor in human colon cancer cells.

Kállay E, Bonner E, Wrba F, Thakker RV, Peterlik M, Cross HS.

Oncol Res. 2003;13(12):551-9.

PMID:
12899245
44.

Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells.

Farhan H, Wähälä K, Cross HS.

J Steroid Biochem Mol Biol. 2003 Mar;84(4):423-9.

PMID:
12732287
45.

Transcriptional inhibition of CYP24 by genistein.

Farhan H, Cross HS.

Ann N Y Acad Sci. 2002 Nov;973:459-62.

PMID:
12485911
46.

Phytoestrogens regulate vitamin D metabolism in the mouse colon: relevance for colon tumor prevention and therapy.

Kállay E, Adlercreutz H, Farhan H, Lechner D, Bajna E, Gerdenitsch W, Campbell M, Cross HS.

J Nutr. 2002 Nov;132(11 Suppl):3490S-3493S. doi: 10.1093/jn/132.11.3490S.

PMID:
12421875
47.

Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells.

Farhan H, Wähälä K, Adlercreutz H, Cross HS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Sep 25;777(1-2):261-8.

PMID:
12270218
48.

Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress.

Kállay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS.

Food Chem Toxicol. 2002 Aug;40(8):1191-6.

PMID:
12067583
50.

Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage.

Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S, Cross HS.

Carcinogenesis. 2001 Sep;22(9):1429-35.

PMID:
11532865

Supplemental Content

Loading ...
Support Center